Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar fkansteiner Wed, 10/04/2023 – 10:34 More: Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar Source: fierce
read moreWith key Mounjaro decision ahead, Eli Lilly shuffles its C-Suite deck kdunleavy Wed, 10/04/2023 – 09:44 More: With key Mounjaro decision ahead, Eli Lilly shuffles its C-Suite deck Source: fierce
read moreThe approach reduces recovery times and lowers rates of complications More: King Faisal Specialist and Research Centre achieves world-first fully robotic liver transplant Source: News
read moreThe companies aim to bring gene therapies to patients sooner than traditional approaches More: Kate Therapeutics and Capsida Biotherapeutics collaborate on gene therapies Source: News
read moreAhead of adcomm, FDA flags ‘systemic bias’ in Amgen’s late-stage Lumakras trial zbecker Tue, 10/03/2023 – 13:41 More: Ahead of adcomm, FDA flags 'systemic bias' in Amgen's late-stage Lumakras trial Source: fierce
read moreFDA spots manufacturing wrinkles in Galderma’s filing for liquid botulinum toxin zbecker Tue, 10/03/2023 – 10:38 More: FDA spots manufacturing wrinkles in Galderma's filing for liquid botulinum toxin Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals